The Australian general practice landscape is changing and so should pharma’s playbook. For years, pharmaceutical companies have focused their energy on reaching doctors. But the real gatekeepers of access, time, and influence increasingly sit just outside the consulting rooms: Practice Managers. They may not prescribe drugs, but they decide who gets in the door, when, and on what terms. In a system under pressure, that power is only growing.
AusDoc is expanding beyond its core doctor audience to include primary care nurses through a strategic partnership with the Australian Primary Health Nurse Association (APNA).
ADHD is no longer peripheral to Australian general practice. Rising patient demand, prolonged specialist wait times, and growing public awareness mean GPs are now central to ongoing ADHD care. For pharmaceutical companies, this creates a clear opportunity, but also exposes the limits of traditional engagement models.
A national hearing healthcare provider partnered with AusDoc to strengthen GP referral preference for their brand, resulting in a 98% uplift in first-choice GP referral rates
Doctors were clear that pharma delivers substantial scientific progress but equally clear that trust hasn’t kept pace. Addressing this gap between high innovation and low trust is exactly where the opportunity lies to reset the doctor–pharma relationship.
Missed the webinar? You can still hear the full and uncensored debrief of what over 1,000 Australian doctors revealed in the AusDoc Big Doctor Survey From Australia’s #1 platform for doctors, AusDoc. Download the webinar recording and slides.
NEXT Pharma Summit Australia is coming to Sydney on October 22–23, 2025 Australia’s #1 platform for doctors, AusDoc brings the voice of the doctor into the conversation, shaping the future of pharma and healthcare in Australia. Use promo code 'ausdoc' for 10% earlybird discount.
Our latest GP survey reveals clear patterns in how Australian doctors are managing menopause with some therapies dominating and others barely used. The findings highlight important opportunities for pharma to support doctors’ decision-making and improve patient care.
While it’s unrealistic for busy GPs to be on top of every rare disease, these survey results point to an opportunity to raise awareness among doctors.
AusDoc continues to stand out as the first choice for GPs, reaffirming its position in the annual readership survey of medical publications (2025) as the most trusted and widely read medical publication.
Australian Doctor has been shortlisted for one of the most prestigious accolades in the publishing industry — Publication of the Year — at the 2025 Mumbrella Publish Awards.
NEXT Pharma Summit Australia is coming to Sydney on October 22–23, 2025 Australia’s #1 platform for doctors, AusDoc brings the voice of the doctor into the conversation, shaping the future of pharma and healthcare in Australia. Use promo code 'ausdoc' for 10% earlybird discount.